Differences and over-time changes in levels of prescription opioid analgesic dispensing from retail pharmacies in Canada, 2005-2010-Reference-Cited by-同舟云学术

Differences and over-time changes in levels of prescription opioid analgesic dispensing from retail pharmacies in Canada, 2005-2010

Published:2011-07-13 Issue:12 Volume:20 Page:1269-1277
ISSN:1053-8569
Container-title:Pharmacoepidemiology and Drug Safety
language:en
Short-container-title:Pharmacoepidemiol Drug Saf

Author:

Fischer Benedikt¹²,Jones Wayne¹,Krahn Murray³⁴,Rehm Jürgen²⁵

Affiliation:

1. Centre for Applied Research in Mental Health and Addictions, Faculty of Health Sciences; Simon Fraser University; Vancouver British Columbia Canada

2. Centre for Addiction and Mental Health; Toronto Ontario Canada

3. Toronto Health Economics and Technology Assessment Collaborative; Toronto Ontario Canada

4. Faculty of Medicine; University of Toronto; Toronto Ontario Canada

5. Dalla Lana School of Public Health; University of Toronto; Toronto Ontario Canada

Funder

Canadian Institutes of Health Research

Ministry of Health and Long-Term Care

Michael Smith Foundation for Health Research Senior Scholar Award

Publisher

Wiley

Subject

Pharmacology (medical),Epidemiology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1002/pds.2190/fullpdf

Reference49 articles.

1. Characterizing the 'awakening elephant': prescription opioid misuse in North America: Epidemiology, harms, interventions;Fischer;Contemp Drug Probl,2008

2. Wanted: a public health approach to prescription opioid abuse and diversion;Joranson;Pharmacoepidemiol Drug Saf,2006

3. National Drug Control Policy and Prescription Drug Abuse: Facts and Fallacies;Manchikanti;Pain Physician,2007

4. The challenge of prescription drug misuse: A review and commentary;Hurwitz;Pain Med,2005

Cited by 65 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The marked oscillatory pattern in prescription opioid utilization in Canada since 2000: Selected observations and questions for outcomes and policy;Pharmacoepidemiology and Drug Safety;2023-12-29

2. Chronic pain and continuity of analgesic treatment during the COVID ‐19 pandemic;Pain Practice;2022-12-23

3. Pronounced Declines in Meperidine in the US: Is the End Imminent?;Pharmacy;2022-11-20

4. Opioid prescribing among new users for non-cancer pain in the USA, Canada, UK, and Taiwan: A population-based cohort study;PLOS Medicine;2021-11-01

5. Patterns, trends and determinants of medical opioid utilization in Canada 2005–2020: characterizing an era of intensive rise and fall;Substance Abuse Treatment, Prevention, and Policy;2021-09-14